161596-47-0

PHTHAL (S)-(+)-GL 2-[(2S)-ox 2-Amino-8-picoline S-Glycidyl Phthalamide Rivaroxaban Impurity R Linezolid EPP Impurity Rivaroxaban Impurity 39 (S)-GLYCIDYL PHTHALIMIDE (S)-N-Glycidylphthalimide N-(S)-Glycidylphthalimide Rivaroxaban Intermediate 2 (S)-(+)-GLYCIDYL PHTHALIMIDE (S)-(+)-GLYCIDYL PHTHALIdime (S)-N-Glycidylphthalimide&gt (S)-(+)-GLYCIDYL PHTHALIMIDEONE (S)-N-Glycidylphthalimide, ≥99% (S)-N-GlycidylphthaliMide, ee: 98% (S)-N-GlycidylphthaliMide, ee: 97.5% (S)-(+)-N-(2,3-Epoxypropyl)pthalaMide (S)-(+)-N-(2,3-Epoxypropyl)phthalimide (S)-2-OXIRANYLMETHYL-ISOINDOLE-1,3-DIONE (S)- (+) - (2,3-Epoxypropyl) phthalimide (S)-N-Glycidylphthalimide, 98.5%, ee: 98% (2S)-2-Oxiranylmethyl-isoindole-1,3-dione S)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-ion (S)-N-Glycidylphthalimide, 98.5%, ee: 97.5% (S)-4-(oxiran-2-ylMethyl)isoindoline-1,3-dione 2-[[(2S)-oxiran-2-yl]methyl]isoindole-1,3-dione 2-(((S)-Oxiran-2yl)Methyl)Isoindoline-1,3-Dione (S)-(+)-GLYCIDYL PHTHALIMIDE ISO 9001：2015 REACH 2-[[(2S)-oxiran-2-yl]methyl]isoindoline-1,3-dione 2-((2S)-OXIRANYLMETHYL)-1H-ISOINDOLE-1,3(2H)-DIONE (2S)-2-(OXIRANYLMETHYL)-1H-ISOINDOLE-1,3(2H)-DIONE (S)-(+)-N-(2,3-Epoxypropyl)phthaliMide >=99.0% (GC) 2-[(2S)-2-oxiranyl Methyl]-1H-isoindole-1,3(2H)-dione 2-[(2S)-oxiran-2-ylmethyl]-1H-isoindole-1,3(2H)-dione 1H-Isoindole-1,3(2H)-dione, 2-[(2S)-2-oxiranylMethyl]- Rivaroxaban intermediates，(S)-(+)-Glycidyl Phthalimide 2-[(2s)-oxirane-2yl methyl]-1H-isoindole-1,3(2H)-dione 2-{[(2S)-oxiran-2-yl]methyl}-2,3-dihydro-1H-isoindole-1,3-dione 2-[(2S)-ox 2-[(2S)-2-oxiranyl Methyl]-1H-isoindole-1,3(2H)-dione (s)-2-oxiranylmethyl-isoindole-1,3-dione/(S)-(+)-Glycidyl Phthalimide ( S ) -2- ( Oxiran - 2 - ylmethyl ) -1H - isoindole - 1,3 ( 2H ) dione (S)-Glycidyl Phthalimide or (S)-2-(oxiran-2-ylmethyl)isoindoline-1,3-dione (S)-2-Oxiranylmethyl-isoindole-1,3-dione (or) (S) (+)- Glycidyl Phthalimide (S)-2-OXIRANYLMETHYL-ISOINDOLE-1,3-DIONE (S)-(+)-GLYCIDYL PHTHALIMIDE (S)-GLYCIDYL PHTHALIMIDE 2-((2S)-OXIRANYLMETHYL)-1H-ISOINDOLE-1,3(2H)-DIONE